CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
senofilcon A with new UV blocker +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03556579
NCT03556579N/ACompleted
CompareCT.gov

The Effects of Contact Lenses With Experimental Dye on Visual Function

Johnson & Johnson Vision Care, Inc.·interventional·Posted Jun 14, 2018·Updated Nov 18, 2019

In Brief

A clinical study evaluating senofilcon A with new UV blocker and senofilcon A for Ametropia. Completed, enrolled 62 participants across 1 site.

Detailed Summary

This is a single-site, two-visit, contralateral, non-dispensing, randomized, controlled and subject-masked study to measure potential benefits of the new UV blocker.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 14, 2018
Enrollment StartMay 15, 2018
Primary CompletionSep 20, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.0 years ago

Interventions

senofilcon A with new UV blockerdevice

Test Lens

senofilcon Adevice

Control Lens